Waystar Holding Corp. (NASDAQ:WAY – Get Free Report) CEO Matthew Hawkins sold 22,462 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $25.04, for a total transaction of $562,448.48. Following the completion of the transaction, the chief executive officer directly owned 1,835,081 shares of the company’s stock, valued at approximately $45,950,428.24. This represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Waystar Stock Up 2.2%
Shares of NASDAQ WAY opened at $25.08 on Friday. The firm’s 50-day moving average is $21.52 and its 200-day moving average is $22.76. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. Waystar Holding Corp. has a 1 year low of $17.26 and a 1 year high of $41.47. The firm has a market capitalization of $4.81 billion, a PE ratio of 35.83, a price-to-earnings-growth ratio of 0.96 and a beta of 0.06.
Waystar (NASDAQ:WAY – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The company had revenue of $319.67 million during the quarter, compared to analysts’ expectations of $316.21 million. Waystar had a return on equity of 7.03% and a net margin of 11.18%.Waystar’s revenue was up 18.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.36 EPS. Equities analysts expect that Waystar Holding Corp. will post 1.47 EPS for the current year.
Hedge Funds Weigh In On Waystar
Analysts Set New Price Targets
Several analysts have issued reports on WAY shares. Barclays upped their price target on shares of Waystar from $25.00 to $27.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $39.00 price target on shares of Waystar in a report on Friday, July 31st. Weiss Ratings cut Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. Wall Street Zen downgraded shares of Waystar from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. Finally, Wolfe Research raised Waystar to an “outperform” rating in a research note on Thursday. Three analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.00.
Check Out Our Latest Analysis on WAY
Waystar Company Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Read More
- Five stocks we like better than Waystar
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
